– USA, CA – WithMe Health, Inc., a medication guidance company, today announced the closing of a Series B financing round of $20 million led by OMERS Ventures and with participation from existing investor Oak HC/FT, along with new investors Section 32, Shulman Ventures and MTS Ventures.
Concurrent with the financing, Michael Yang, Managing Partner of OMERS Ventures, will join the Board of Directors and Brian Marcotte, past CEO and President of the Business Group on Health, will join the Advisory Board.
“We are excited to partner with Joe Murad and the WithMe Health team as they bring a new medication management model to a very traditional pharmacy benefit management market. The early traction they’ve had getting new customers on board is impressive and a clear indication that the need for a product like this is significant and timely,” said Michael Yang, Managing Partner, OMERS Ventures.
Coupled with recent partnerships with Centivo and Consociate Health, the new funding will support further growth of the client base as well as an extension of the core offering.
“The pandemic has really focused everyone on the healthcare system and the ways in which it’s falling short,” said CEO, Joe Murad. “This is an excellent time for innovation across all aspects of the pharmacy value chain, from how people receive medication to our area of focus: getting people on the right medication and helping them to understand if it’s working. There are a few bigger problems than the misaligned incentives that govern medication selection and utilization.”
About the Health
WithMe Health was founded on the belief that improved health outcomes and lower total cost of care can be achieved through better medication guidance. Their personalized medication guidance solution tailors medication selection to the individual and guides members through every step of their medication journey. The company is headquartered in Silicon Valley and has raised $40 million.
For more information: https://www.withmehealth.com/
About OMERS Ventures
OMERS is one of Canada’s largest defined benefit pension plans, with CAD$109 billion in net assets as of December 31, 2019. OMERS Ventures currently manages CAD$2 billion and has made more than 50 investments in disruptive technology companies across North America and Europe.
For more information: https://www.omersventures.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.